Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Conditions: Ovarian High Grade Serous Adenocarcinoma; Platinum-Resistant Ovarian Carcinoma Interventions: Drug: Atovaquone; Procedure: Biopsy; Procedure: Computed Tomography; Procedure: Paracentesis Sponsors: Emory University; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Ovarian Cancer | Ovaries | Paracentesis | Research